Search

Displaying results 7511 - 7520 of 10000 in total
  1. Drug

    Terdecamycin

    go.drugbank.com/drugs/DB19720
    Experimental

    Terdecamycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Terdecamycin is a antibiotic, produced by Streptomyces strain. … Terdecamycin has a monoisotopic molecular weight of 585.31 Da.

  2. Drug

    Cyprolidol

    go.drugbank.com/drugs/DB19771
    Experimental

    Cyprolidol is a small molecule drug. Cyprolidol has a monoisotopic molecular weight of 301.15 Da.

  3. Drug

    Ancriviroc

    go.drugbank.com/drugs/DB19773
    Experimental

    Ancriviroc is a small molecule drug. The usage of the INN stem '-viroc' in the name indicates that Ancriviroc is a CCR5 (Chemokine CC motif receptor 5) receptor antagonist. … Ancriviroc has a monoisotopic molecular weight of 556.2 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Pamicogrel

    go.drugbank.com/drugs/DB19812
    Experimental

    Pamicogrel is a small molecule drug. Pamicogrel has a monoisotopic molecular weight of 448.15 Da.

    Categories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Nobiprostolan

    go.drugbank.com/drugs/DB19814
    Experimental

    Nobiprostolan is a small molecule drug. Nobiprostolan has a monoisotopic molecular weight of 468.35 Da.

  6. Drug

    MIP-1095 I-131

    go.drugbank.com/drugs/DB14978
    Investigational

    MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).

  7. Drug

    Martinostat

    go.drugbank.com/drugs/DB14979
    Investigational

    Martinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast Cancer).

  8. Drug

    Nomacopan

    go.drugbank.com/drugs/DB14991
    Investigational

    Nomacopan is under investigation in clinical trial NCT03427060 (Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms).

    Categories: Recombinant Protein Inhibitor of Complement Factor 5
  9. Drug

    Pegunigalsidase alfa

    go.drugbank.com/drugs/DB14992
    ApprovedInvestigational

    Pegunigalsidase alfa (PRX-102) is a recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease, a rare genetic disorder characterized … to a different glycosylation pattern.

  10. Drug

    Pateclizumab

    go.drugbank.com/drugs/DB14997
    Investigational

    Pateclizumab is under investigation in clinical trial NCT01225393 (A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared … With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis).